Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

18.1%

59 terminated/withdrawn out of 326 trials

Success Rate

77.4%

-9.1% vs industry average

Late-Stage Pipeline

16%

52 trials in Phase 3/4

Results Transparency

51%

103 of 202 completed trials have results

Key Signals

28 recruiting103 with results41 terminated18 withdrawn

Enrollment Performance

Analytics

N/A

121(55.3%)

Phase 3

27(12.3%)

Phase 4

25(11.4%)

Phase 2

22(10.0%)

Phase 1

21(9.6%)

Early Phase 1

3(1.4%)

219Total

N/A(121)

Phase 3(27)

Phase 4(25)

Phase 2(22)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (326)

Showing 20 of 326 trials

NCT04604782Phase 1Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients

Role: lead

NCT05553899Not ApplicableRecruiting

Utility of PET-MRI in Surveillance of Paediatric Brain Tumours

Role: collaborator

NCT07219238Phase 2Recruiting

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Role: lead

NCT02894749Not ApplicableCompleted

Evaluation of 3D Rotational Angiography After EVAR

Role: collaborator

NCT06769594Completed

Next Generation CT System

Role: lead

NCT04540107Phase 1Recruiting

Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

Role: collaborator

NCT05835284Completed

Clinical Data Collection On Advanced CT System

Role: lead

NCT06702917Recruiting

GSI Cardiac on Revolution Apex - US

Role: lead

NCT07538544Early Phase 1Not Yet Recruiting

MCE Molecular Imaging for ICI Myocarditis

Role: collaborator

NCT00567684Not ApplicableActive Not Recruiting

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Role: collaborator

NCT07472491Phase 2Recruiting

A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients

Role: lead

NCT07263815Not ApplicableActive Not Recruiting

EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventional PET

Role: collaborator

NCT07169825Not ApplicableRecruiting

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

Role: collaborator

NCT07215845Not ApplicableRecruiting

Pars Healing on MRI

Role: collaborator

NCT06398730Phase 1Completed

A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

Role: lead

NCT06639828Phase 4Recruiting

Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging

Role: lead

NCT05625659Not ApplicableRecruiting

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

Role: collaborator

NCT07394140Not ApplicableNot Yet Recruiting

NMT EasyFit Sensor and Cable

Role: lead

NCT07272161Not ApplicableNot Yet Recruiting

Pilot Evaluation of the StarGuide Next Generation SPECT/CT System